RadioMedix lands $40M Series A investment to advance cancer treatments

October 10, 2022 Chandler France

RadioMedix focuses on treatments for rare and aggressive cancers, specifically developing and advancing targeted alpha therapy and radiopharmaceuticals.

Altuve ALDS stats: .324/.410/.667, 10HR, 5 2B, 15 BB over 120 PA’s
Two minutes may be all you have to escape a home fire — the nation’s most frequent disaster

Related

You May Also Like

2 years after Jason Landry vanished, retired FBI agent believes he may have been a crime victim

jeweler recommendation for resize and repair

YMCA of Greater Houston to build new aquatics center for around $3.5M